chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sick in bed; exhaustion; nausea; severe body pain/terrible body pain; chills; hot last night so he may have had a fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick in bed), MYALGIA (severe body pain/terrible body pain), CHILLS (chills), PYREXIA (hot last night so he may have had a fever) and FATIGUE (exhaustion) in a 69-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had COVID last summer).    On 30-Sep-2023 at 5:00 PM, the patient received fourth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 01-Oct-2023, the patient experienced MYALGIA (severe body pain/terrible body pain), CHILLS (chills) and PYREXIA (hot last night so he may have had a fever). On an unknown date, the patient experienced ILLNESS (Sick in bed), FATIGUE (exhaustion) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Sick in bed), MYALGIA (severe body pain/terrible body pain) and CHILLS (chills) had not resolved and PYREXIA (hot last night so he may have had a fever), FATIGUE (exhaustion) and NAUSEA (nausea) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Patient woke up on early Sunday with chills and terrible body pain. All day on the previous day and on the day of reporting patient still experienced it. Patient was hot last night so patient might had a fever. Patient had to miss work on the day of reporting. Patient hadn't had any previous reactions aside for sore arm for his previous vaccinations.   This case was linked to MOD-2023-743178 (Patient Link).
I received the Moderna vaccine for COVID-19. With the first shot, I noticed an escalation of sleep deprivation. I was already dealing with sleep deprivation and it was getting better. Upon receiving the shot, it became much worse. The second shot gave me seizures. I was having a conversation with a friend then suddenly could not recognize him. I also had spasms. I had no control over my hands and body and was shaking profusely.  The area I was vaccinated on was suddenly paining a lot. Then the seizures began.
DIZZINESS; STARTED WITH SHAKES/TREMOR; RUNS/DIARRHEA; ARM SORENESS; GOT OUT OF BED TOOK 3 STEPS, FELL FORWARD; SAT IN ROCKING CHAIR, CALLED OUT OF WORK, STOOD UP AND WHOLE ROOM STARTED SPINNING; This spontaneous report received from a patient concerned a 62 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included smoker, and non-alcoholic, and other pre-existing medical conditions included the patient had no known drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose was not reported, one total, administered on 17-MAR-2021 in left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 18-MAR-2021, the subject experienced dizziness. On 18-MAR-2021, the subject experienced started with shakes. On 18-MAR-2021, the subject experienced runs. On 18-MAR-2021, the subject experienced arm soreness. On 18-MAR-2021, the subject experienced got out of bed took 3 steps, fell forward. On 18-MAR-2021, the subject experienced sat in rocking chair, called out of work, stood up and whole room started spinning. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from runs on 18-MAR-2021, was recovering from arm soreness, had not recovered from dizziness, and started with shakes, and the outcome of got out of bed took 3 steps, fell forward and sat in rocking chair, called out of work, stood up and whole room started spinning was not reported. This report was non-serious.
got a terrible case of the flu 10 years ago when I got the shot; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 23-Nov-2020 and a live follow up was received on 28-Nov-2020 (both processed together).  This case involves a patient of unknown demographics who had a terrible case of the flu 10 years ago when patient got the shot (influenza), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date 10 years age, the patient developed a terrible case of the flu when patient got the shot (influenza) (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE. Patients doctors advised never to get the shot again and patient have not.   No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
pain in the shoulder blade at the injection site arm; This is a spontaneous report from a contactable consumer (patient's daughter). A 94-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 16Feb2021 (Batch/Lot number was not reported) (at the age of 94-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included flu vaccine, shingles vaccine and pneumonia vaccine with no side effects. The patient experienced pain in the shoulder blade at the injection site arm on 17Feb2021 with outcome of unknown. It was reported that on 16Feb2021 the patient received her first dose of the Pfizer covid vaccine and the next day she stated experiencing pain in the shoulder blade at the injection site arm. The reporter wanted to know about it and mentioned that she was disappointed that her mother (patient) experienced this side effect. It was mentioned that the patient tolerated flu, shingles, and pneumonia vaccine with no side effects. It was added that the patient got the first vaccine on 16Feb2021. She was ok until the next day. She started complaining the following day of pain in her shoulder blade on the same side as the injection site which was the left arm. It has been over a week and she was still complaining about it. The reporter mentioned that she knows some of the side effects are typical muscle aches, pains, and headaches, the same as the flu shot. It had been going on for too long and the reporter was concerned. The patient had been taking TYLENOL on and off, but not consistently because she doesn't want to take needless medication if it was not really bothering her. The patient has had no other side effects. No fever, no aches elsewhere, and no headache. The reporter asked if this was a typical reaction for this vaccine and if there had been reports before. The reporter was wondering if she should be really concerned. She mentioned that she doesn't like to see her mom (patient) in pain. She added that it was not a crippling type of pain where she can't function. She just has a sad face. Therapeutic measures were taken as a result of pain in the shoulder blade at the injection site arm.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
My arm is red; I have a bump; I have a bump, it is itchy and hot; I have a bump, it is itchy and hot; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 16Apr2021 at 09:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and the patient reported that "I can't have NSAIDS" (known allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN), cetirizine hydrochloride (ZYRTEC) and ascorbic acid (VITAMIN C) and unspecified vitamins; all for unspecified indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 26Mar2021 at 09:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Apr2021 at 10:00, the patient's arm was red and had a bump, it was itchy and hot. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm was red and had a bump, it was itchy and hot was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Headache,  Body aches,  102* temperature.  Tylenol, water, rest 36 hours
pt rcvd vax; developed red rash around needle mark; slept frequently; very mushy; running nose w/ yellowish mucus; t 102; cried throughout night; torso rash;
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Pharmacist). The reporter is the patient.  A 59-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 at 15:00 as dose 4 (booster), single (Lot number: GJ2524), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, sngle (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2023, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test positive. Therapeutic measures were taken as a result of drug ineffective, covid-19, including Paxlovid from 26Apr2023 to 01May2023. Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events Drug ineffective, Covid-19 and the use of suspect product Comirnaty cannot be fully excluded.
Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 30-DEC-2014  the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a licensed practical nurse concerning a 22-week-old patient who on 07-JAN-2007, 19-APR_2007, and 04-JUN-2007 was vaccinated with the first, second, and third doses of Rotateq. There were no adverse symptoms and no other information available. There was no product quality complaint. Additional information has been requested.
2 d after vaccine pt. developed runny nose and cough. Next day F > 101. Seen 5th d after w/f = 103.5.
I had a sore arm for about a day after receiving the vaccine.  On 03/29/2023, I tested positive for strep throat at the doctor's office.  I tested negative at home for COVID-19 on 03/29/2023. I was put on an antibiotic for the infection.
This is a spontaneous report received from a contactable consumer or other non-HCP. A female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient had pain in extremity/soreness in the hand (non-serious), with outcome of not recovered. Additional information: Reporter stated his wife was having some soreness, he wanted to check on her behalf. Reporter stated his wife got it yesterday, so she's having a little bit more pain than he did. Reporter stated he just wanted to check on the medication. The pharmacy said they can take Tylenol. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Developed Pericarditis from a virus.  Covid tests were negative.  Needed to have a Pericardial Window procedure.
About one (1) hour following dose #1 - persistent coughing; frequency and intensity of symptoms slowly subsided through the date of dose #2 (6/13/21).  About thirty (30) minutes following dose #2 - persistent coughing, congestion and wheezing/trouble breathing. Wheezing/trouble breathing subsided after about four (4) days; persistent coughing and congestion continues.
03/29/06 rash on face, trunk and arms noted today. Child has headache and slight fever 101.9. Brother and Dad have strep. Dx: Varicella papules on trunk and arms.
diagnosed with pneumonia; diagnosed with pneumonia; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age (78 unknown unit) receive pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at single dose for immunization.  The patient's medical history and concomitant medications did not be reported. The patient was diagnosed with pneumonia on 01Feb2020 but he had already had the vaccines available, but with the Covid 19 virus in circulation, who knows what he was experiencing, but the Levoquin antibiotic did the trick and patient did not have to be hospitalized. The outcome of event pneumonia was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Patient received Kinrix vaccine at 6 months on 4/23/2019. On 5/2/2019 I  called and spoke with mother of patient. I inquired as to how the patient was doing after her 6 month well child check and immunizations. Patient?s mother stated ?She is doing absolutely wonderful! She handled her 6 month vaccines much better than her 4 month vaccines.? I inquired as to if the patient seemed fussy or sore at all after her vaccines. Patient mother advised ?Not at all, she has been trucking along just fine.? I stated I was happy to hear that and advised patient mother the reason I wanted to know how patient was doing was because she received the combination vaccine Kinrix (dtap-ipv) and children under the age of 4 years old do not get that combination they get dtap and polio via separate injections  or Pediarix combination. Patient mother stated that patient is fine and has no complaints. Advised patient mother she may contact our office at any time if she has further questions and concerns. I provided callback number. Patient mother inquired if the patient has to get shots at 9 months. Advised that the vaccine schedule would not have vaccines scheduled at 9 months unless the patient is behind in vaccines. Patient mother had no further questions. ?
the area got very hard and grew quickly; light rash; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number K2397, expiry date 17th December 2021) for prophylaxis.   Concurrent medical conditions included rash.   On 11th January 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 11th January 2020, less than a day after receiving Shingrix, the patient experienced induration. In January 2020, the patient experienced rash. On an unknown date, the outcome of the rash was recovering/resolving and the outcome of the induration was unknown.   It was unknown if the reporter considered the rash and induration to be related to Shingrix.  Additional details were provided as follows:  The patient experienced a light rash for months under the area where she received her 2nd dose of Shingrix. The patient experienced the area got very hard and grew quickly and now covers most of her upper arm where she received Shingrix.
Patient reported facial swelling to the right cheek area and pain around the left eye socket.  These symptoms appeared overnight, and the patient first noticed them upon awakening.
Fatigue, approximately 11am day of (may have been exacerbated by less sleep the night before), (lasted 36 hours). Chills (lasted an hour or so), spiked fever (lasted maybe 8 hours mostly while sleeping), muscle soreness/tightness (shoulders/neck, Lasted 12-15 hours,) Headache ( lasted about 12-15 hours, and I never get headaches).
On March 11 at5pm, after shooting basketball for 50 minutes, I had no medical issues. On March 24 at 6:40pm, after shooting basketball for 30 minutes, I had a heart attack with a coronary artery LAD 100% blockage and was treated with a stent procedure right after a visit to the ER.
Swelling of tongue. Started on the right side in two hours the entire tongue was swollen. Resumed all medications as prescribed and have not had similar reactions. The only variant was the fact I had the second vaccine three days prior to swelling. I also could not see well while driving and was fatigued and disoriented for about 14 days after my second dose of Phizer.
Left eye drooping; numbness; tingling of nose and upper lip area and left side of face began about 30 post vaccine; tingling of nose and upper lip area and left side of face began about 30 post vaccine; tingling of nose and upper lip area and left side of face began about 30 post vaccine; This is a spontaneous report received from a contactable consumer or other non hcp. A 60-years-old female patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 27Feb2021 15:45,at the age of 60 years old,as Dose 2,single for covid-19 immunization. Medical history included interstitial cystitis and drug hypersensitivity from an unknown date and unknown if ongoing.     There were no concomitant medications.The patient previously took tigan and experienced drug hypersensitivity, bnt162b2 for covid-19 immunization.The patient experienced left eye drooping, numbness, tingling of nose and upper lip area and left side of face began about 30 post vaccine on 27Feb2021 16:15.The outcome of the event was recovering.The patient had not received any other vaccine within 4 weeks.The patient was not diagnosed with covid prior vaccination and not tested post vaccination.  Follow-up (12May2021): Follow-up attempts are completed. No further information is expected.
administered 0.1cc to left forearm but did not produce a wheal. re-administered another 0.1cc to right forearm and able to produce a wheal.
My father in law suffered a heart attacked on the day he received his second shot. at the time of this he was staying in our house where he wasn't found until two days later when we received a call from his work saying he never showed up or called in to work. The medical examiner told us that prior to the second vaccine in the last few weeks he had suffered some sort of heart issue that damaged his heart, but wasn't big enough for him to notice or think anything of it. The timeline the medical examiner gave us would have been after receiving the first vaccine. He then received his second Vaccine on a Thursday which was the last time anyone heard from him and he didn't show up to work Friday and was found Saturday after we were notified he didn't show up to work and we called 911. The medical examiner said he suffered a heart attack. The medical examiner said they had to write the death date on Saturday because that was when he was found, but the last anyone heard of him was prior to getting the vaccine and then he missed work the very next day(which was Friday).
A physician reported that her 12-year-old son received an injection of FluShield (influenza virus vaccine, trivalent, types A & B (2002-2003 formula) on 11-Dec-2003.   Medical History: The reporter indicated that the patient has no relevant medical history.  Product Detail: Indication for Flu Shield (2002-2003 Formula) was immunization. Product was administered on 11-Dec-2003.  Concomitant Therapy: Concomitant medications and vaccines were not administered.  Event Details: On 11-Dec-2003, a male patient received a dose of FluShield from a lot that had expired in June 2003. On 12-Dec-2003, the patient developed an injection site reaction characterized by pain. The reporter indicated the patient's arm was "treated with ice and it's better today." No additional information was available at the time of this report.
inconsolable crying for 8 hrs w/in 24 hrs p/multiple immun; t102-103 (used forehead thermometer);
Arm was swollen; Red from the shoulder all the way down to her elbow; All the way around, itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Arm was swollen), VACCINATION SITE ERYTHEMA (Red from the shoulder all the way down to her elbow) and VACCINATION SITE PRURITUS (All the way around, itching) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE SWELLING (Arm was swollen), VACCINATION SITE ERYTHEMA (Red from the shoulder all the way down to her elbow) and VACCINATION SITE PRURITUS (All the way around, itching). At the time of the report, VACCINATION SITE SWELLING (Arm was swollen), VACCINATION SITE ERYTHEMA (Red from the shoulder all the way down to her elbow) and VACCINATION SITE PRURITUS (All the way around, itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset of the events, a causal relationship cannot be excluded.
Patient states that immediately after the injection she felt a "jolt" from the injection site to the elbow. Discomfort is still present as of this filing.
57 hours after vaccine, I woke up with stomach cramps, diarrhea, chills/sweats feeling awful and soon after had a sudden syncopal event while walking back from the bathroom. I recovered, laid in bed and then within 15-20 minutes had diarrhea again so went to the bathroom and had another syncopal episode on the toilet (both witnessed by my husband) with diarrhea during this episode. I then went to the ER and was treated with 3L IV fluids for hypotension, IV zofran and bentyl. I left the ER within about 3 hours. still have been fatigued but was up most of that night. my body all hurts but I fell into my bedframe face first during the first syncope so would relate that to those symptoms/injuries.